CAPTRUST Financial Advisors’s DexCom DXCM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $2.66M | Buy |
42,403
+972
| +2% | +$67.7K | ﹤0.01% | 1066 |
|
|
2025
Q4 | $2.75M | Buy |
41,431
+13,913
| +51% | +$899K | 0.01% | 932 |
|
|
2025
Q3 | $1.85M | Sell |
27,518
-5,717
| -17% | -$452K | ﹤0.01% | 1067 |
|
|
2025
Q2 | $2.9M | Buy |
33,235
+3,661
| +12% | +$287K | 0.01% | 811 |
|
|
2025
Q1 | $2.02M | Buy |
29,574
+1,422
| +5% | +$116K | 0.01% | 901 |
|
|
2024
Q4 | $2.19M | Buy |
28,152
+5,101
| +22% | +$378K | 0.01% | 850 |
|
|
2024
Q3 | $1.55M | Buy |
23,051
+1,022
| +5% | +$83.9K | ﹤0.01% | 967 |
|
|
2024
Q2 | $2.5M | Sell |
22,029
-247
| -1% | -$31.2K | 0.01% | 725 |
|
|
2024
Q1 | $3.09M | Sell |
22,276
-22,084
| -50% | -$2.78M | 0.01% | 643 |
|
|
2023
Q4 | $5.5M | Buy |
44,360
+6,781
| +18% | +$693K | 0.02% | 528 |
|
|
2023
Q3 | $3.51M | Buy |
37,579
+10,664
| +40% | +$1.2M | 0.01% | 643 |
|
|
2023
Q2 | $3.46M | Buy |
26,915
+7,166
| +36% | +$867K | 0.01% | 626 |
|
|
2023
Q1 | $2.29M | Sell |
19,749
-356
| -2% | -$39.9K | 0.01% | 695 |
|
|
2022
Q4 | $2.28M | Buy |
20,105
+1,091
| +6% | +$120K | 0.01% | 670 |
|
|
2022
Q3 | $1.53M | Buy |
19,014
+4,205
| +28% | +$356K | 0.01% | 761 |
|
|
2022
Q2 | $1.1M | Sell |
14,809
-1,963
| -12% | -$179K | 0.01% | 788 |
|
|
2022
Q1 | $2.15M | Buy |
16,772
+4,008
| +31% | +$438K | 0.01% | 581 |
|
|
2021
Q4 | $1.71M | Buy |
12,764
+528
| +4% | +$75.9K | 0.01% | 610 |
|
|
2021
Q3 | $1.67M | Sell |
12,236
-3,280
| -21% | -$414K | 0.01% | 569 |
|
|
2021
Q2 | $1.66M | Sell |
15,516
-1,444
| -9% | -$139K | 0.02% | 551 |
|
|
2021
Q1 | $1.52M | Buy |
16,960
+8,868
| +110% | +$832K | 0.02% | 541 |
|
|
2020
Q4 | $748K | Buy |
8,092
+892
| +12% | +$79.6K | 0.01% | 696 |
|
|
2020
Q3 | $745K | Buy |
7,200
+868
| +14% | +$90.7K | 0.01% | 597 |
|
|
2020
Q2 | $634K | Buy |
6,332
+796
| +14% | +$71.2K | 0.01% | 635 |
|
|
2020
Q1 | $353K | Sell |
5,536
-204
| -4% | -$12.7K | 0.01% | 672 |
|
|
2019
Q4 | $315K | Buy |
5,740
+5,456
| +1,921% | +$259K | 0.01% | 824 |
|
|
2019
Q3 | $11K | Hold |
284
| – | – | ﹤0.01% | 1460 |
|
|
2019
Q2 | $11K | Buy |
284
+184
| +184% | +$5.78K | ﹤0.01% | 1467 |
|
|
2019
Q1 | $3K | Hold |
100
| – | – | ﹤0.01% | 1620 |
|
|
2018
Q4 | $3K | Hold |
100
| – | – | ﹤0.01% | 1424 |
|
|
2018
Q3 | $4K | Hold |
100
| – | – | ﹤0.01% | 1389 |
|
|
2018
Q2 | $2K | Hold |
100
| – | – | ﹤0.01% | 1404 |
|
|
2018
Q1 | $2K | Hold |
100
| – | – | ﹤0.01% | 1236 |
|
|
2017
Q4 | $1K | Buy |
+100
| New | +$1.3K | ﹤0.01% | 1210 |
|
Other funds holding DXCM
VCM
VPM
CAPTRUST Financial Advisors's DXCM Position: Q1 2026 in Review
CAPTRUST Financial Advisors increased its DexCom (DXCM) stake by 2.3% in Q1 2026, buying an estimated $67.7K and bringing the position to 42,403 shares worth $2.66M. The position accounts for ﹤0.01% of the portfolio, ranked #1066.
CAPTRUST Financial Advisors first reported a position in DXCM in Q4 2017 and has held it in 34 quarters since. The position peaked at $5.5M in Q4 2023. 956 funds tracked by Wall St. Rank hold DXCM as of Q1 2026.
- CAPTRUST Financial Advisors held 42,403 shares of DexCom worth $2.66M as of Q1 2026.
- CAPTRUST Financial Advisors bought 972 DexCom shares in Q1 2026, an estimated $67.7K.
- DexCom made up ﹤0.01% of CAPTRUST Financial Advisors's portfolio in Q1 2026, its #1066 holding.
- CAPTRUST Financial Advisors first reported a position in DexCom in Q4 2017 and has held it in 34 quarters since.
- CAPTRUST Financial Advisors's DexCom position peaked at $5.5M in Q4 2023.
- 956 funds tracked by Wall St. Rank held DexCom as of Q1 2026.
Based on CAPTRUST Financial Advisors's 13F filing for Q1 2026, filed 15 May 2026.